NM_000432.4:c.274+25_274+26dupGT

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000432.4(MYL2):​c.274+25_274+26dupGT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0765 in 1,369,570 control chromosomes in the GnomAD database, including 1,729 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.078 ( 549 hom., cov: 31)
Exomes 𝑓: 0.076 ( 1180 hom. )

Consequence

MYL2
NM_000432.4 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.360

Publications

2 publications found
Variant links:
Genes affected
MYL2 (HGNC:7583): (myosin light chain 2) This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]
MYL2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 10
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
  • congenital fiber-type disproportion myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 12-110914159-G-GAC is Benign according to our data. Variant chr12-110914159-G-GAC is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 43462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.202 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYL2NM_000432.4 linkc.274+25_274+26dupGT intron_variant Intron 4 of 6 ENST00000228841.15 NP_000423.2 P10916Q6IB42
MYL2NM_001406745.1 linkc.232+25_232+26dupGT intron_variant Intron 3 of 5 NP_001393674.1
MYL2NM_001406916.1 linkc.217+25_217+26dupGT intron_variant Intron 4 of 6 NP_001393845.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYL2ENST00000228841.15 linkc.274+26_274+27insGT intron_variant Intron 4 of 6 1 NM_000432.4 ENSP00000228841.8 P10916

Frequencies

GnomAD3 genomes
AF:
0.0776
AC:
11644
AN:
149990
Hom.:
550
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0819
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0457
Gnomad ASJ
AF:
0.0351
Gnomad EAS
AF:
0.213
Gnomad SAS
AF:
0.165
Gnomad FIN
AF:
0.0682
Gnomad MID
AF:
0.0649
Gnomad NFE
AF:
0.0702
Gnomad OTH
AF:
0.0533
GnomAD2 exomes
AF:
0.178
AC:
20713
AN:
116462
AF XY:
0.186
show subpopulations
Gnomad AFR exome
AF:
0.168
Gnomad AMR exome
AF:
0.0751
Gnomad ASJ exome
AF:
0.0860
Gnomad EAS exome
AF:
0.338
Gnomad FIN exome
AF:
0.138
Gnomad NFE exome
AF:
0.158
Gnomad OTH exome
AF:
0.144
GnomAD4 exome
AF:
0.0764
AC:
93138
AN:
1219476
Hom.:
1180
Cov.:
16
AF XY:
0.0794
AC XY:
48757
AN XY:
613876
show subpopulations
African (AFR)
AF:
0.0809
AC:
2295
AN:
28370
American (AMR)
AF:
0.0336
AC:
1393
AN:
41412
Ashkenazi Jewish (ASJ)
AF:
0.0365
AC:
851
AN:
23334
East Asian (EAS)
AF:
0.209
AC:
7626
AN:
36568
South Asian (SAS)
AF:
0.152
AC:
11816
AN:
77864
European-Finnish (FIN)
AF:
0.0721
AC:
3567
AN:
49480
Middle Eastern (MID)
AF:
0.0564
AC:
292
AN:
5174
European-Non Finnish (NFE)
AF:
0.0680
AC:
61632
AN:
905792
Other (OTH)
AF:
0.0712
AC:
3666
AN:
51482
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
4285
8569
12854
17138
21423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2286
4572
6858
9144
11430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0776
AC:
11645
AN:
150094
Hom.:
549
Cov.:
31
AF XY:
0.0801
AC XY:
5859
AN XY:
73186
show subpopulations
African (AFR)
AF:
0.0820
AC:
3359
AN:
40966
American (AMR)
AF:
0.0456
AC:
685
AN:
15034
Ashkenazi Jewish (ASJ)
AF:
0.0351
AC:
121
AN:
3444
East Asian (EAS)
AF:
0.212
AC:
1091
AN:
5136
South Asian (SAS)
AF:
0.164
AC:
775
AN:
4726
European-Finnish (FIN)
AF:
0.0682
AC:
695
AN:
10186
Middle Eastern (MID)
AF:
0.0664
AC:
19
AN:
286
European-Non Finnish (NFE)
AF:
0.0702
AC:
4727
AN:
67336
Other (OTH)
AF:
0.0522
AC:
108
AN:
2068
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
510
1021
1531
2042
2552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
144
288
432
576
720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0343
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 26, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

274+26_274+27insGT in intron 4 of MYL2: This variant is not expected to have cl inical or pathological significance because it does not alter an amino acid resi due and is not located in the highly conserved region of the 5' splice site. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cardiomyopathy Benign:1
Sep 30, 2020
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142567411; hg19: chr12-111351963; API